Playback speed
10 seconds
SGO 2024 Insights: "Final OS Data of Relacorilant, a Selective Glucocorticoid Receptor Modulator, in Combination With Nab-Paclitaxel in Pts With Recurrent Platinum-Resistant Ovarian Cancer"
By
Insights from 2024 SGO Annual Meeting
FEATURING
Nicoletta Colombo
By
Insights from 2024 SGO Annual Meeting
FEATURING
Nicoletta Colombo
53 views
March 26, 2024
Login to view comments.
Click here to Login